SIGA Technologies, Inc.
$4.57
▲
1.35%
2026-04-21 09:25:00
www.siga.com
NGM: SIGA
Explore SIGA Technologies, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$327.41 M
Current Price
$4.57
52W High / Low
$9.62 / $4.29
Stock P/E
14.06
Book Value
$2.78
Dividend Yield
0%
ROCE
11.76%
ROE
11.23%
Face Value
—
EPS
$0.32
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
49
Beta
1.06
Debt / Equity
0.38
Current Ratio
11.83
Quick Ratio
9.1
Forward P/E
2.97
Price / Sales
3.3
Enterprise Value
$158.16 M
EV / EBITDA
6.52
EV / Revenue
1.67
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Net margin remains healthy.
- Valuation is not stretched on P/E basis.
Cons
- Operating margin is thin.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Alpha Teknova, Inc. | $2.91 | — | $157.01 M | — | -17.67% | -22.83% | $7.48 / $1.91 | $1.28 |
| 2. | Aurora Cannabis Inc. | $3.72 | — | $285.82 M | — | 1.34% | -15.51% | $9.33 / $4.29 | $6.8 |
| 3. | Zhengye Biotechnology Holding Limited | $0.95 | — | $47.54 M | 0.05% | 4.81% | -6.38% | $14.3 / $0.68 | $0.91 |
| 4. | Viatris Inc. | $14.78 | — | $17.2 B | 3.23% | 0.84% | -21.08% | $16.47 / $7.39 | $12.78 |
| 5. | SCYNEXIS, Inc. | $1.07 | — | $47.85 M | — | -30.16% | -16.48% | $1.31 / $0.56 | $1.13 |
| 6. | BioXcel Therapeutics, Inc. | $1.2 | — | $32.49 M | — | 557.9% | 74.14% | $8.08 / $1.01 | $-4.28 |
| 7. | Esperion Therapeutics, Inc. | $2.02 | — | $510.15 M | — | 36.51% | 6.57% | $4.17 / $0.69 | $-1.23 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 3.79 M | 2.62 M | 81.12 M | 7.04 M | 81.47 M | — |
| Operating Profit | -9.5 M | -10.22 M | 45.68 M | -2.26 M | 57.09 M | — |
| Net Profit | -5.43 M | -6.37 M | 35.48 M | -0.41 M | 45.76 M | — |
| EPS in Rs | -0.08 | -0.09 | 0.5 | -0.01 | 0.64 | 0.02 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 94.57 M | 138.72 M | 139.92 M | 110.78 M |
| Operating Profit | 23.7 M | 69.98 M | 83.62 M | 42.7 M |
| Net Profit | 23.28 M | 59.21 M | 68.07 M | 33.9 M |
| EPS in Rs | 0.32 | 0.83 | 0.95 | 0.47 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 219.47 M | 244.34 M | 254.35 M | 195.04 M |
| Total Liabilities | 20.65 M | 28.53 M | 57.49 M | 24.88 M |
| Equity | 198.82 M | 215.8 M | 196.86 M | 170.16 M |
| Current Assets | 212.86 M | 231.04 M | 238.99 M | 185.79 M |
| Current Liabilities | 17.99 M | 25.33 M | 54.12 M | 21.52 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 43.47 M | 48.76 M | 94.8 M | 41.61 M |
| Investing CF | -0.36 M | -0.04 M | -0.02 M | 0 M |
| Financing CF | -43.55 M | -43.46 M | -43.42 M | -45.96 M |
| Free CF | 43.12 M | 48.72 M | 94.78 M | 41.61 M |
| Capex | -0.36 M | -0.04 M | -0.02 M | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -0.86% | 26.31% | — | — |
| Earnings Growth % | -13.01% | 100.76% | — | — |
| Profit Margin % | 42.69% | 48.65% | 30.61% | — |
| Operating Margin % | 50.45% | 59.76% | 38.55% | — |
| Gross Margin % | 68.57% | 75.52% | 70.25% | — |
| EBITDA Margin % | 50.84% | 60.15% | 39.01% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-04-07 | $0.6 |
| 2025-04-29 | $0.6 |
| 2024-03-25 | $0.6 |
| 2023-05-15 | $0.45 |
| 2022-05-16 | $0.45 |
Stock Splits
No stock split history available.